HNF1A inhibition induces the resistance of pancreatic cancer cells to gemcitabine by targeting ABCB1
Open Access
- 1 June 2019
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 44, 403-418
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 51 references indexed in Scilit:
- MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genesOncogenesis, 2013
- Genome-Wide “Pleiotropy Scan” Identifies HNF1A Region as a Novel Pancreatic Cancer Susceptibility LocusCancer Research, 2011
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Pancreatic CancerNew England Journal of Medicine, 2010
- CD44‐positive cells are responsible for gemcitabine resistance in pancreatic cancer cellsInternational Journal of Cancer, 2009
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic CancerScience, 2009
- Common Coding Variants of the HNF1A Gene Are Associated With Multiple Cardiovascular Risk Phenotypes in Community-Based Samples of Younger and Older European-American AdultsCirculation: Cardiovascular Genetics, 2009
- Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue specific hormonal expression of human multidrug resistance-associated protein 2 (abcc2)Toxicology and Applied Pharmacology, 2008
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic AnalysesScience, 2008
- Hormone Response of Rodent Phenylalanine Hydroxylase Requires HNF1 and the Glucocorticoid ReceptorBiochemical and Biophysical Research Communications, 2001